| |
Author |
Title |
Year |
Publication |
Volume |
Pages  |
Links |
|
|
Klumpp, L.; Sezgin, E.C.; Skardelly, M.; Eckert, F.; Huber, S.M. |
KCa3.1 channels and glioblastoma: in vitro studies |
2017 |
Current Neuropharmacology |
|
|
|
|
|
Guerrero, P.A.; Tchaicha, J.H.; Chen, Z.; Morales, J.E.; McCarty, N.; Wang, Q.; Sulman, E.P.; Fuller, G.; Lang, F.F.; Rao, G.; McCarty, J.H. |
Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression |
2017 |
Oncogene |
|
|
|
|
|
Rosager, A.M.; Sorensen, M.D.; Dahlrot, R.H.; Boldt, H.B.; Hansen, S.; Lathia, J.D.; Kristensen, B.W. |
Expression and prognostic value of JAM-A in gliomas |
2017 |
Journal of Neuro-Oncology |
|
|
|
|
|
Foro Arnalot, P.; Pera, O.; Rodriguez, N.; Sanz, X.; Reig, A.; Membrive, I.; Ortiz, A.; Granados, R.; Algara, M. |
Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide |
2017 |
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
|
|
|
|
|
Ludwig, K.; Kornblum, H.I. |
Molecular markers in glioma |
2017 |
Journal of Neuro-Oncology |
|
|
|
